SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd (INDO) is trending as escalating Middle East tensions drive crude oil prices higher, sparking community anticipation for a significant short squeeze and potential drilling updates. Many are closely watching for INDO to follow other energy runners, fueled by the historical context of its past surges during similar global events.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is surging amid reports of its CEO's substantial stock purchase, signaling strong confidence, and speculation about a potential partnership with OpenAI to sell ads. This has ignited community discussion about a significant short squeeze and a potential rebound for the recently oversold ad tech platform.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending as escalating Middle East tensions, including reported disruptions in the Strait of Hormuz and attacks on energy infrastructure, drive a surge in crude prices. The community is hotly debating the potential for prolonged supply impacts and inflation versus expectations of a quick de-escalation that could reverse the current "war premium."

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is seeing immense interest as escalating Middle East tensions, particularly the closure of the Strait of Hormuz and Qatar's halt of LNG production, trigger a global supply shock and spike shipping rates. This perfectly positions the company's extensive spot-market exposure and owned fleet for significant gains, a narrative amplified by recent strong earnings and crucial legal victories.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending due to intensifying geopolitical tensions with Iran, including U.S. military actions in the Strait of Hormuz, which are fueling concerns about rising oil prices and broader market instability. The community is also actively debating the bearish implications of proposed U.S. restrictions on AI chip exports, contributing to widespread calls for further market downside.

SSgA Active Trust - State Street SPDR Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF (DIA) is currently trending amid escalating geopolitical tensions in the Middle East, primarily driven by concerns over oil supply disruptions and the potential for a prolonged conflict. Community discussion is polarized, with many anticipating market downturns while others view recent dips as buying opportunities, betting on historical market resilience and potential de-escalation.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is actively discussed as geopolitical tensions in the Middle East intensify, leading to community debate on whether its defense segment will finally boost the stock amidst ongoing concerns about commercial aircraft production rates and quality control, despite some analysts maintaining a bullish stance.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines is seeing intense debate as its Q4 earnings miss, coupled with escalating Middle East tensions and rising fuel costs, fuels widespread bearish sentiment and concerns about operational disruptions. However, some investors eye a potential rebound based on positive 2026 guidance and technical indicators, despite a backdrop of union discontent with current management.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending after its HLP004 Phase 2 study results for Generalized Anxiety Disorder led to a sharp stock decline, sparking confusion and ironic commentary about its "HELP" ticker symbol within the community. Investors are debating the true efficacy of the data, with some attributing the sell-off to typical biotech "sell the news" reactions, while others question the study's design and clear benefits.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

Escalating Middle East geopolitical tensions, particularly disruptions near the Strait of Hormuz and impacts on LNG facilities, are driving speculative interest in BOIL, with the community actively debating if the U.S. natural gas market can remain insulated given domestic oversupply.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bayer Q4 Earnings Match Estimates, Xarelto and Eylea Pull Down Sales

BAYRY posts in-line Q4 earnings but revenues miss on lower Xarelto and Eylea sales. 2026 sales guidance signals steady growth ahead.

Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Sanofi and Bayer

LLY, JNJ, SNY and BAYRY ride strong pipelines and M&A momentum as Large-Cap Pharma rebounds in 2026 despite pricing and patent risks.

4 Large-Cap Pharma Stocks to Watch as Industry Recovery Gains Steam

In the Large-Cap Pharmaceuticals industry, Lilly, J&J, BAYRY and Sanofi are worth retaining as the industry shows some recovery.

CYTK Posts a Wider-Than-Expected Q4 Loss, Advances Myqorzo Launch Plans 

CYTK reports a wider-than-expected Q4 loss as expenses rise, but Myqorzo wins FDA nod and global expansion advances, with $1.22B cash fueling 2026 catalysts.

Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?

Here is how Align Technology (ALGN) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.

 ETFs in Spotlight as Trump Moves to Mobilize Defense Production Act

Trump invokes the Defense Production Act to secure phosphorus and glyphosate. MOO could gain as domestic agricultural and materials players ramp up. 

Bayer (BAYRY) Surges 6.0%: Is This an Indication of Further Gains?

Bayer (BAYRY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

NVS Reports Positive Late-Stage Data on Kidney Disease Drug Vanrafia 

Novartis posts positive phase III ALIGN data for Vanrafia in IgAN, showing slower kidney decline as it eyes full approval in 2026.

Will Eylea Sales Decline Weigh on REGN's Top Line in 2026?

Regeneron foresees further Eylea decline in 2026 as biosimilars loom, but Eylea HD, Dupixent and Libtayo aim to steady revenues.

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Bayer AG - ADR

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $COST earnings Thursday?

Current Price	$10.89
Prev Close	$11.01
Open	$10.83
Dividend Yield	0.46%
50-Day Moving Average	$12.31
Beta	0.43
Avg. Volume	1.73M
PE Ratio	-126.84

52-Week High	$14.85
52-Week Low	$5.30
Market Capitalization	$43.27B
EPS (Annual)	-$0.7025
Price to Book	1.24
Revenue Per Employee	$543,158.75

BAYRY
Bayer AG (ADR)

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BAYRY News

BAYRYBayer AG (ADR)